logo
Select company
Select metric
$ 52.63MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
79
Sector
87
Industry
90
History
93
$ 13.64Close
$ 6.5 - $ 17.02 52-Week Range
Ticker Information

Ticker

SRZN

Company Name

SURROZEN INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SURROZEN INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SRZN - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 52.63M
3/31/2025$ 74.36M
12/31/2024$ -1.48M
9/30/2024$ -2.7M
6/30/2024$ 1.55M
3/31/2024$ -236K
12/31/2023$ 11.64M
9/30/2023$ 8.46M
6/30/2023$ 19.63M
3/31/2023$ 13.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SURROZEN INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 987.19K.
  • Over the past 5 years, SURROZEN INC's average CF - Chg. Cash has been $ 7.59M.
  • The median CF - Chg. Cash for SURROZEN INC during this period was $ 375.59K
  • SURROZEN INC reached its highest CF - Chg. Cash over the past 5 years at $ 74.36M.
  • The lowest CF - Chg. Cash recorded by SURROZEN INC in the same timeframe $ -35.56M

SURROZEN INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CRVO : CERVOMED INC $ -1.69MCUE : CUE BIOPHARMA INC $ -2.54MTCRX : TSCAN THERAPEUTICS INC $ -72.77MFATE : FATE THERAPEUTICS INC $ -618KHYFT : MINDWALK HOLDINGS CORP $ 1.37MCBUS : CIBUS INC $ 6.44MVRCA : VERRICA PHARMACEUTICALS INC $ -16.53MOVID : OVID THERAPEUTICS INC $ -1.28MIRD : OPUS GENETICS INC $ -8.98MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -29.99M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

SRZN - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -35.56M

Minimum

Sep 30, 2022

$ 74.36M

Maximum

Mar 31, 2025

$ 7.59M

Average

$ 375.59K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.12M with a standard deviation of $ 45.01M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 137.58M
average$ 1.12M
median$ 104K
std$ 45.01M